(Reuters) -Biohaven said on Monday its experimental treatment for a rare neuromuscular disorder failed to show statistically significant difference in improving motor function in a late-stage trial, ...

By targeting specific stages of the cycle, chemotherapy drugs aim to stop cancer cells from growing and dividing. Cancer cells grow through a sequence called the cell cycle, which consists of ...

Regulators need to know that our most important health care problem is not that people are taking too many prescription drugs ...

An international team of researchers have developed a promising new drug that could help combat the spread of treatment-resistant malaria. The breakthrough development is the first to adapt an ...

If someone chooses chemotherapy, whether or not it's in combination with other treatments, oncologists will use a drug or ...

The U.S. Food and Drug Administration has expanded the age indication for Theranica's Nerivio, making it the first and only ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

Amneal Pharmaceuticals resubmitted a new drug application for its migraine treatment to the Food and Drug Administration, and additionally received approval for its diabetes and obesity treatment. The ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Most deaths from cancer are caused not by the original tumor but by metastasis—the spread of cancer cells to other parts of ...